Drug Profile
Research programme: P 62 project - NutriCology/Phytopharm
Latest Information Update: 26 May 2010
Price :
$50
*
At a glance
- Originator NutriCology
- Developer Phytopharm
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Asthma; Glomerulonephritis; Thrombocytopenia
Most Recent Events
- 26 May 2010 Discontinued - Preclinical for Asthma in United Kingdom (unspecified route)
- 26 May 2010 Discontinued - Preclinical for Glomerulonephritis in United Kingdom (unspecified route)
- 26 May 2010 Discontinued - Preclinical for Thrombocytopenia in United Kingdom (unspecified route)